MaxCyte, Inc. (MXCT) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $1.07M; Additional Paid in CapitalUSD $434.26M; Treasury Stock, Common, ValueUSD $1.48M; Retained Earnings (Accumulated Deficit)USD $-275.11M.
- 2026-03-31: Common Stock, Value, IssuedUSD $1.07M; Additional Paid in CapitalUSD $433.05M; Treasury Stock, Common, ValueUSD (m); Retained Earnings (Accumulated Deficit)USD $-266.23M.
- 2025-12-31: Common Stock, Value, IssuedUSD $1.07M; Additional Paid in CapitalUSD $431.90M; Treasury Stock, Common, ValueUSD (m); Retained Earnings (Accumulated Deficit)USD $-261.48M.
- 2025-09-30: Common Stock, Value, IssuedUSD $1.07M; Additional Paid in CapitalUSD $431.10M; Treasury Stock, Common, ValueUSD (m); Retained Earnings (Accumulated Deficit)USD $-251.89M.
MaxCyte, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Treasury Stock, Common, Value USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Treasury Stock, Common, Shares shares | Treasury Stock, Value, Acquired, Cost Method USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Treasury Stock, Shares, Acquired shares |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.07M | $434.26M | $1.48M | $-275.11M | $158.75M | 1.31M | 3 month · $1.48M 6 month · $1.48M | 3 month · $1.16M | 6 month · 1.31M |
| 2026-03-31 | $1.07M | $433.05M | (m) | $-266.23M | $167.89M | (m) | (m) | 3 month · $1.14M | (m) |
| 2025-12-31 | $1.07M | $431.90M | (m) | $-261.48M | $171.49M | (m) | (m) | 12 month · $9.21M | (m) |
| 2025-09-30 | $1.07M | $431.10M | (m) | $-251.89M | $180.28M | (m) | (m) | 3 month · $1.95M | (m) |
| 2025-06-30 | $1.07M | $429.13M | (m) | $-239.47M | $190.72M | (m) | (m) | 3 month · $3.51M | (m) |
| 2025-03-31 | $1.06M | $425.46M | (m) | $-227.11M | $199.41M | (m) | (m) | 3 month · $3.04M | (m) |
| 2024-12-31 | $1.06M | $422.05M | (m) | $-216.85M | $206.25M | (m) | (m) | 12 month · $13.08M | (m) |
| 2024-09-30 | $1.05M | $418.50M | (m) | $-206.26M | $213.30M | (m) | (m) | 3 month · $3.37M | (m) |
| 2024-06-30 | $1.05M | $414.91M | (m) | $-194.70M | $221.26M | (m) | (m) | 3 month · $3.56M | (m) |
| 2024-03-31 | $1.04M | $410.64M | (m) | $-185.32M | $226.36M | (m) | (m) | 3 month · $3.02M | (m) |
| 2023-12-31 | $1.04M | $406.93M | (m) | $-175.80M | $232.17M | (m) | (m) | 12 month · $13.98M | (m) |
| 2023-09-30 | $1.04M | $402.86M | (m) | $-170.52M | $233.38M | (m) | (m) | 3 month · $3.61M | (m) |
| 2023-06-30 | $1.03M | $399.22M | (m) | $-159.27M | $240.98M | (m) | (m) | 3 month · $3.52M | (m) |
| 2023-03-31 | $1.03M | $395.55M | (m) | $-148.76M | $247.82M | (m) | (m) | 3 month · $3.28M | (m) |
| 2022-12-31 | $1.02M | $390.82M | (m) | $-137.88M | $253.97M | (m) | (m) | 12 month · $11.75M | (m) |
| 2022-09-30 | $1.02M | $386.48M | (m) | $-133.07M | $254.43M | (m) | (m) | 3 month · $3.20M | (m) |
| 2022-06-30 | $1.02M | $382.84M | (m) | $-126.63M | $257.22M | (m) | (m) | 3 month · $2.97M | (m) |
| 2022-03-31 | $1.02M | $379.54M | (m) | $-118.37M | $262.18M | (m) | (m) | 3 month · $2.46M | (m) |
| 2021-12-31 | $1.01M | $376.19M | (m) | $-114.30M | $262.90M | (m) | (m) | 12 month · $7.96M | (m) |
| 2021-09-30 | $1.00M | $372.54M | (m) | $-109.43M | $264.12M | (m) | (m) | 3 month · $2.29M | (m) |
| 2021-06-30 | $847.20K | $184.72M | (m) | $-106.75M | $78.82M | (m) | (m) | 3 month · $1.91M | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | $81.29M | (m) | (m) | 3 month · $1.32M | (m) |
| 2020-12-31 | $773.80K | $127.67M | (m) | $-95.22M | $33.23M | (m) | (m) | 12 month · $2.47M | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | $34.99M | (m) | (m) | 3 month · $598.00K | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | $37.21M | (m) | (m) | 3 month · $559.00K | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | $11.09M | (m) | (m) | 3 month · $547.60K | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | $13.60M | (m) | (m) | 12 month · $1.75M | (m) |
| 2018-12-31 | (m) | (m) | (m) | (m) | $12.28M | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |